Category: Protected PCI


Dr. Mark Grise Shares Advice on Access and Patient Management at Scripps 2015

The talk entitled “Tips and Tricks: Access and Patient Management” was given by Dr. Mark Grise, Medical Director of the Cardiac Catheterization Laboratory at Sacred Heart Hospital in Pensacola, Florida at the 26th annual 2015 Scripps Cardiovascular Interventions Conference on Tuesday, October 27, 2015. Dr. Grise’s talk was part of the pre-conference session titled “A New Procedure in the Cath Lab: Protected PCI Treating Complex and Higher-Risk Indicated Patients (CHIP).”Before PCI—percutaneous coronary intervention—Dr. Grise recommends always doing a femoral angiogram to assess the tortuosity, stenosis, calcification, and size of the common femoral artery, which needs to be > 4.6 cm. The target zone for entry is the middle of the femoral head on the common femoral artery, which is seen under fluoroscopy in the anteroposterior projection. Before proceeding, Dr. Grise obtains access on the other side and takes a picture of the planned Impella side.Continue readingDr. Mark Grise Shares Advice on Access and Patient Management at Scripps 2015

Dr. John Lasala Discusses Benefits of Protected PCI at Scripps 2015

Protected percutaneous coronary intervention (PCI) with the Impella® 2.5 heart pump was the focus of the talk by Dr. John Lasala, Director of Interventional Cardiology at the Washington University School of Medicine in St. Louis, Missouri. His talk was titled “Preparing for a Growing Population in the Cath Lab" and was presented at the 26th annual 2015 Scripps Cardiovascular Interventions Conference on Tuesday, October 27, 2015. Dr. Lasala was a featured speaker in the preconference session called “A New Procedure in the Cath Lab: Protected PCI Treating Complex and Higher-Risk Indicated Patients (CHIP).”Dr. Lasala began by describing the Impella 2.5, which is the only hemodynamic support device proven safe and effective for use in treating elective and urgent high-risk PCI patients, and which may reduce peri and post-procedural adverse events. The Impella heart pump is designed to protect the patient hemodynamically during a high-risk PCI procedure.Continue readingDr. John Lasala Discusses Benefits of Protected PCI at Scripps 2015

Roundtable Discusses the Growing Need for Protected PCI

There is a growing need in the cath lab to treat more high risk patients, per the CHIP initiative. Dr. Ajay Kirtane, Dr. John Lasala, Dr. Jeff Popma and Dr. Jeff Moses discuss. Subscribe or join the conversation by following us on Twitter: @ProtectedPCI IMP-820-16

Protected PCI Offers New Option for Patients Turned Down for CABG or Traditional PCI

Improving the health of patients and offering the best possible treatments is the primary ethos and goal of any medical professional. A new procedure called Protected PCI, with the Impella 2.5 pump, offers cardiologists the chance to reduce complications and improve outcomes for a wide range of high risk patients. These patients are severe heart disease patients who are characterized as being hemodynamically stable, but who have a depressed left ventricular ejection fraction (< 35%), complex coronary anatomy such as triple vessel disease or left main disease, and various comorbidities (such as heart failure, diabetes, advanced age, peripheral vascular disease, complex lesions, history of angina, prior surgeries).These “high risk” patients often present to the cath lab as either a scheduled PCI case – they have been turned down for CABG or traditional PCI but have little to no options left to improve their heart failure symptoms, or, they present urgently with unstable angina and are in need of revascularization with hemodynamic support.Continue readingProtected PCI Offers New Option for Patients Turned Down for CABG or Traditional PCI